Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D0O8MU
|
||||
| Former ID |
DIB018589
|
||||
| Drug Name |
3-bicyclo[2.2.1]hept-2-yl-benzene-1,2-diol
|
||||
| Drug Type |
Small molecular drug
|
||||
| Indication | Discovery agent | Investigative | [1] | ||
| Structure |
|
Download2D MOL |
|||
| Formula |
C13H16O2
|
||||
| InChI |
InChI=1S/C13H16O2/c14-12-3-1-2-10(13(12)15)11-7-8-4-5-9(11)6-8/h1-3,8-9,11,14-15H,4-7H2
|
||||
| InChIKey |
DWWJNUSFHLSDSW-UHFFFAOYSA-N
|
||||
| PubChem Compound ID | |||||
| PubChem Substance ID | |||||
| Target and Pathway | |||||
| Target(s) | Potassium voltage-gated channel subfamily B member 1 | Target Info | Blocker (channel blocker) | [2] | |
| Reactome | Voltage gated Potassium channels | ||||
| Glucagon-like Peptide-1 (GLP1) regulates insulin secretion | |||||
| WikiPathways | Calcium Regulation in the Cardiac Cell | ||||
| Potassium Channels | |||||
| References | |||||
| REF 1 | (http://www.guidetopharmacology.org/) Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 2569). | ||||
| REF 2 | Novel neuroprotective K+ channel inhibitor identified by high-throughput screening in yeast. Mol Pharmacol. 2004 Jan;65(1):214-9. | ||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.